A carregar...
Tau spread, apoE, inflammation, and more: Rapidly evolving basic science in AD
To date, Alzheimer's disease (AD) drug candidates have produced negative results in human trials and progress moving new targets out of the laboratory and into trials has been slow. However, based on three decades of previous work, there is reason to hope that amyloid-based and other novel ther...
Na minha lista:
| Publicado no: | Neurol Clin |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5417853/ https://ncbi.nlm.nih.gov/pubmed/28410655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ncl.2017.01.001 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|